The Asia-Pacific CGT Excellence Awards 2026 seeks to recognize exceptional Cell & Gene Therapy pioneers, researchers, innovators, and manufacturers who are driving rapid advancements in new therapies, R&D, and manufacturing. Featuring top Cell & Gene Therapy leaders in the industry, along with the latest developments in cell & gene therapy research, advancements in technologies, and best practices in manufacturing, the awards celebrate extraordinary leaders and trendsetters of today, while inspiring the innovators of tomorrow. The Awards Ceremony will take place in conjunction with the 10th Annual Cell & Gene Therapy World Asia 2026, in-person on 30th June 2026, in Singapore.

WHY OUR AWARDS?

IMAPAC has been serving the Biopharma industry for the past 15 years. We pride ourselves in organising conferences in a revolutionising industry and providing new opportunities for those who participate.

Criteria for Nomination

  • The company should be an organization that is involved in biopharmaceutical development and/or manufacturing.
  • The company should have a notable presence in APAC.
  • The company should have displayed significant developments in the past few years.

Criteria to Win the Awards

  • Criteria to Win the AwardsBased on the number of nominations and assessment, the top 5–7 entries under each category will be shortlisted.
  • From these top 5–7 entries, the award winner will be determined completely (100%) by voting results from the biopharma community.
  • Companies with the most votes will win the award in their respective category.

AWARD WINNERS

Excellence & Achievement Awards

AWARD CATEGORIES
WINNERS
Most Promising Gene Therapy Pipeline in APAC
Loxegen, Australia
Most Promising Off-the-Shelf Therapy Pipeline in APAC
ARCE Therapeutics, Taiwan
Most Promising Off-the-Shelf Therapy Pipeline in APAC
Magellan Stem Cells, Australia
Most Promising CAR-T Pipeline in APAC
UWELL Biopharma, Taiwan
Emerging CAR-T Innovator in Asia
Eximmium, Singapore

Innovation & Development Awards

AWARD CATEGORIES
WINNERS
Best In Vivo Gene Therapy Developer in APAC
AnGes, Japan
Emerging Leader in Allogeneic Cell Therapy
Cartherics, Australia

Regional Leadership Awards

AWARD CATEGORIES
WINNERS
CGT Company of the Year - Japan
Takeda Pharmaceutical Company, Japan
CGT Company of the Year - India & South Asia
Dr. Reddy's, India
CGT Company of the Year - Australia & New Zealand
Chimeric Therapeutics, Australia
CGT Company of the Year - Southeast Asia
Bifarma Adiluhung (Regenic), Indonesia

Cell & Gene Therapy Bioprocessing Technologies

AWARD CATEGORIES
WINNERS
Best Cell & Gene Therapy Supplier Award: Clinical Trials
Novotech CRO
Best Cell & Gene Therapy Supplier Award: Gene Editing
GenScript
Best CDMO for Cell & Gene Therapy
Lonza
Best Cell & Gene Therapy Supplier Award: Upstream Processing
Sartorius
Best Cell & Gene Therapy Supplier Award: Downstream Processing
Cytiva
Best Cell & Gene Therapy Supplier Award: Fill & Finish
West Pharmaceutical Services
Overall Best Cell & Gene Therapy Supplier Award
Lonza
Best Cell & Gene Therapy Supplier Award: Manufacturing Scale-Up
Sartorius
Global Leadership in AI-Driven Healthcare Innovation Award
Unbanked Co., Ltd.

Cell & Gene Therapy Supply Chain Excellence

AWARD CATEGORIES
WINNERS
Best Cell & Gene Therapy Supplier Award: Cold Chain Logistics
Cryoport Systems
Best Cell & Gene Therapy Supplier Award: Supply Chain Excellence
QuickSTAT, a Kuehne+Nagel Company
Best Clinical Trial Logistics Provider Award: Cell & Gene Therapy
Marken.